Aristea Therapeutics
DeAnne Reid, Director of Operations and Business Development, has deep experience in successfully leading Operations across a range of industries. At Aristea, she is accountable for Finance, HR, IT and Administration. Prior to joining Aristea, she led administrative planning for all functional areas at Ardea Biosciences and managed specific projects including FDA Advisory Committee preparation and two successful Business Development deals. Prior to joining Ardea, she held administrative and operations roles at Genentech, The Advantage Network and Tang Capital Management.
This person is not in any offices
Aristea Therapeutics
Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development.